| GC32020-20mg |
|
214487-45-3 |
|
0 |
C38H40N4O3 |
|
|
|
| GC32020-10mg |
|
214487-45-3 |
|
0 |
C38H40N4O3 |
|
|
|
| GC32020-5mg |
|
214487-45-3 |
|
0 |
C38H40N4O3 |
|
|
|
| GC32020-1mg |
|
214487-45-3 |
|
0 |
C38H40N4O3 |
|
|
|
| GC32019-100mg |
|
2215120-36-6 |
Interferon receptor agonist
|
0 |
C12H22N4O2 |
|
|
|
| GC32019-50mg |
|
2215120-36-6 |
Interferon receptor agonist
|
0 |
C12H22N4O2 |
|
|
|
| GC32019-25mg |
|
2215120-36-6 |
Interferon receptor agonist
|
0 |
C12H22N4O2 |
|
|
|
| GC32019-10mg |
|
2215120-36-6 |
Interferon receptor agonist
|
0 |
C12H22N4O2 |
|
|
|
| GC32019-5mg |
|
2215120-36-6 |
Interferon receptor agonist
|
0 |
C12H22N4O2 |
|
|
|
| GC32019-10mM(1mLinDMSO) |
|
2215120-36-6 |
Interferon receptor agonist
|
0 |
C12H22N4O2 |
|
|
|
| GC32018-20mg |
|
120635-47-4 |
|
0 |
C20H21N3O |
|
|
|
| GC32018-10mg |
|
120635-47-4 |
|
0 |
C20H21N3O |
|
|
|
| GC32018-5mg |
|
120635-47-4 |
|
0 |
C20H21N3O |
|
|
|
| GC32018-1mg |
|
120635-47-4 |
|
0 |
C20H21N3O |
|
|
|
| GC32017-20mg |
|
879399-82-3 |
|
0 |
C19H21Cl2N3O4S2 |
|
|
|
| GC32014-20mg |
|
120165-51-7 |
Asthma relating compound 1
|
0 |
C17H19N3O3S2 |
|
|
|
| GC32014-10mg |
|
120165-51-7 |
Asthma relating compound 1
|
0 |
C17H19N3O3S2 |
|
|
|
| GC32014-5mg |
|
120165-51-7 |
Asthma relating compound 1
|
0 |
C17H19N3O3S2 |
|
|
|
| GC32014-1mg |
|
120165-51-7 |
Asthma relating compound 1
|
0 |
C17H19N3O3S2 |
|
|
|
| GC32012-100mg |
|
50-69-1 |
D-Ribose(mixture of isomers)
|
0 |
C5H10O5 |
|
|
|
